001448114 000__ 05284cam\a2200565Ii\4500
001448114 001__ 1448114
001448114 003__ OCoLC
001448114 005__ 20230310004222.0
001448114 006__ m\\\\\o\\d\\\\\\\\
001448114 007__ cr\cn\nnnunnun
001448114 008__ 220712s2022\\\\sz\a\\\\ob\\\\001\0\eng\d
001448114 019__ $$a1335114087
001448114 020__ $$a9783030827434$$q(electronic bk.)
001448114 020__ $$a3030827437$$q(electronic bk.)
001448114 020__ $$z9783030827427
001448114 020__ $$z3030827429
001448114 0247_ $$a10.1007/978-3-030-82743-4$$2doi
001448114 035__ $$aSP(OCoLC)1335120459
001448114 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dYDX$$dEBLCP$$dOCLCQ
001448114 049__ $$aISEA
001448114 050_4 $$aRL801
001448114 08204 $$a615.7/78$$223/eng/20220712
001448114 24500 $$aCutaneous drug hypersensitivity :$$bclinical features, mechanisms, diagnosis, and management /$$cAndreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud, editors.
001448114 264_1 $$aCham :$$bSpringer,$$c[2022]
001448114 264_4 $$c©2022
001448114 300__ $$a1 online resource :$$billustrations (chiefly color)
001448114 336__ $$atext$$btxt$$2rdacontent
001448114 337__ $$acomputer$$bc$$2rdamedia
001448114 338__ $$aonline resource$$bcr$$2rdacarrier
001448114 504__ $$aIncludes bibliographical references and index.
001448114 5050_ $$aPart I. General aspects of drug hypersensitivity -- Chapter 1. Terminology, classifications, chronology -- Chapter 2. Epidemiology -- Chapter 3. Clinical manifestations: Cutaneous signs and syndromes -- Chapter 4. Clinical manifestations: Other organs (kidney, gut, heart, brain etc.) -- Chapter 5. Danger signs in drug hypersensitivity and severity SCORES -- Chapter 6. Pathomechanisms in Drug Hypersensitivities -- Part II. Diagnostic methods -- Chapter 7. Skin tests -- Chapter 8. Serological tests -- Chapter 9. T cell tests -- Chapter 10. Basophil activation tests -- Chapter 11. Histopathology of drug induced exanthemas -- Part III. Management -- Chapter 12. Drug desensitization in immediate-type hypersensitivity -- Chapter 13. Documentation allergy card/pass -- Part IV. Drug hypersensitivity in specific populations -- Chapter 14. Children and Adolescents -- Chapter 15. HIV-Infection and AIDS -- Chapter 16. Oncology. immune checkpoint Inhibitors -- Chapter 17. MC releasing syndromes in drug hypersensitivity -- Part V. Eliciting Drugs -- Chapter 18. Penicillins -- Chapter 19. Cephalosporin Allergy -- Chapter 20. Other Antibiotics -- Chapter 21. Other Antiinfectious drugs -- Chapter 22. Analgesics and non-steroidal antiphlogistic drugs -- Chapter 23. Periinterventional hypersensitivity: Anesthetic drugs and materials -- Chapter 24. Muscle relaxants -- Chapter 25. Anticoagulants -- Chapter 26. Biological drugs -- Chapter 27. Hormones (delayed) -- Chapter 28. Vaccines -- Chapter 29. Antiepileptic and psychotropic drugs -- Chapter 30. PROTON PUMP INHIBITORS -- Chapter 31. Diagnostic agents -- Chapter 32. Hypersensitivity to blood pressure agents -- Chapter 33. Iron preparations -- Chapter 34. Vitamins and supplements -- Chapter 35. Anti-tumor drugs / Cytostatics -- Chapter 36. Photosensitizing drugs -- Chapter 37. Topically applied drugs -- Chapter 38. Additives: Preservatives, Antioxidants (sulfites), Colors, dyes and other.
001448114 506__ $$aAccess limited to authorized users.
001448114 520__ $$aThis book covers all aspects of hypersensitivity to drugs, providing practical information for non-specialist physicians as well as addressing issues of interest to practitioners in different specialties and presenting the expert knowledge required by specialist allergists and immunologists. The opening, general section discusses basics such as clinical manifestations, histopathology, mechanisms, risk factors, drug hypersensitivity in particular populations, and the full range of diagnostic methods. The second part of the book provides concise information on the most important drug classes and guides the reader on how to proceed when patients present with a suspected reaction. For each drug class, the current level of evidence for use of the different diagnostic tools, including skin tests, provocation tests, and in vitro tests, is clarified, and management options, outlined. The inclusion of helpful tables and algorithms is designed to aid in decision making. Drug hypersensitivity is among the more complex allergological issues, and this book will meet the needs of general practitioners, internists, and specialists.
001448114 588__ $$aDescription based on print version record.
001448114 650_0 $$aDermatologic agents$$xSide effects.
001448114 650_0 $$aDrug-exanthems.
001448114 650_6 $$aAgents dermatologiques$$0(CaQQLa)201-0034124$$xEffets secondaires.$$0(CaQQLa)201-0377435
001448114 650_6 $$aDermatite médicamenteuse.$$0(CaQQLa)201-0007216
001448114 655_0 $$aElectronic books.
001448114 7001_ $$aBircher, A. J.$$q(Andreas J.),$$eeditor.$$1https://isni.org/isni/0000000030893752
001448114 7001_ $$aMaibach, Howard I.,$$eeditor.$$1https://isni.org/isni/0000000114665802
001448114 7001_ $$aBrockow, Knut,$$eeditor.
001448114 7001_ $$aBarbaud, Annick,$$eeditor.
001448114 77608 $$iPrint version:$$tCutaneous drug hypersensitivity.$$dCham : Springer, 2022$$z9783030827427$$w(OCoLC)1295099287
001448114 852__ $$bebk
001448114 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-82743-4$$zOnline Access$$91397441.1
001448114 909CO $$ooai:library.usi.edu:1448114$$pGLOBAL_SET
001448114 980__ $$aBIB
001448114 980__ $$aEBOOK
001448114 982__ $$aEbook
001448114 983__ $$aOnline
001448114 994__ $$a92$$bISE